chrisvoncsefalvay/vaers-outcomes huggingface dataset:
01/18/2022 in the evening began complaining of head ache and stomach or abdominal pains that would not go away,  was steady. Contacted the doctor, since this was an ongoing headache 01/21/2022 had virtual visit with doctor. Verbal observation and talked about Flonase, and eating prunes to monitor and trying methods to elevate symptoms and hydration. Out from school, 3 days returned on 01/25/2022. Pain scale to .5 01/27/2022 ongoing issue headache and abdominal.
Child very anxious about receiving vaccines- vomited immediately following vaccines. Color pale lips colorless. No history fever, allergies or recent illness cold cloth applied to forehead and laid pt. down. Left office 15 minutes later recovered.
I felt like having the flu, my body was aching, I had a fever for 3 or 4 days, I felt like crap, I was exhausted, I pretty much slept for like a week. I did not go to the doctor because I was expecting to be sick. On 07/14/2021 I went to the doctor because I had a fever again and my throat was pretty much closed up and really sore, a never ending headache, brain foggy. Every day I have like a giant headache and very foggy which is very annoying.  They gave me antibiotics and did not do any medical tests which is very annoying.
Fever and Fatigue after vaccine. Treated with Tylenol and ibuprofen, symptoms have resolved.
Pt had 1st dose 1/27/2021, had normal mammogram 2/2021.  Got second vaccine 2/24/2021, 2 weeks later developed 3.1cm axillary lump found to be ER+, PR-, HER2 - breast cancer with 2 affected nodes.  No family history of breast cancer, no previous abnormal mammograms.
Woke up during night w/ chills fever. Next morning was achy; tired; headache - stayed on sofa under cover until 11:00 AM; tried to move around; noticed a red spot on arm that shots were given in Thurs afternoon. Applied ice; arm is extremely sore; did not feel like eating; slept a little better Thurs night; moved around some on Fri, still had a few chills; Sat 2:00 PM noticed another large area on arm; applied ice; Sunday AM had a nurse tried look at red spot - she said it was still warm and I should apply heat. Sunday night arm is moving better.
A nurse reported the occurrence of vomiting in an 18-month-old female who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  The vaccine provider submitted this report directly to VAERS.  The subject had no relevant medical history, concurrent conditions, or concurrent medications.  The subject experienced no adverse events following previous immunizations.  On 01/29/2003, the subject received her fourth injection of Infanrix (lot number DTPA586A9).  On the same date, she received an injection of inactivated poliomyelitis virus vaccine (IPOL).  On 01/30/2003 the subject developed a "high" fever, swelling of the left thigh that extended from hip to knee, and vomiting.  She was seen by a physician.  The events resolved after a "couple of days."  The reporting nurse considered the events to be related to Infanrix administration.  Comment: This is one of four subjects from this facility, out of more than 30 children immunized, who experienced adverse events following receipt of two lots of Infanrix.  Please see reports A0399834A, A0399836A and A0399837A.
Patient described small vesicles, some the size of a nickel along the trigeminal nerve on her face. This occurred 2 days after vaccine. Her physician prescribed oral and topical anti-viral medication on 4-6-20. Conditions resolved.
I had a run to bathroom with chronic case of diarrhea and waste, the chemical was stink so badly that I had to open windows to get stink out; I had a run to bathroom with chronic case of diarrhea and waste, the chemical was stink so badly that I had to open windows to get stink out; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on 23Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It told that they scheduled the patient for 13Feb2021 for the second dose. Consumer stated that the patient did his/her first dose and everything was good until last night (in Jan2021), just after midnight last night the patient had a run to the bathroom with a chronic case of diarrhea and the waste was so, the chemical was, stink so badly that the patient had to open the windows to get the stink out. Never had a problem like that ever. The patient wanted to know if he/she could stink from the dose of the vaccine that she/he got as side effects. The outcome of the events was unknown.  Information on the Lot/Batch Number has been requested.
Area where shots given is very painful and had a 3 inch radius of redness, and arm felt hard.
Patient presented to the ED with increasing shortness of breath, fever, and tachypnea. He was found to have COVID-19 pneumonia. He was admitted for further management. He was discharged from the hospital 12 days later in stable condition.
Left arm pain for first 2 days.  Malaise for first week,  swollen lymph nodes and cough for 2 months. bronchospasm for 4 months
Patient developed bright red bruising and soreness underneath the arm. (Not in the area the shot was given.) It is not a local reaction, no warmth. Appears like bruising in the initial stages.
Patient stated had tingling in face, itching, Lose of smell, as well as all other reported covid symptoms minus (fever,lost of taste) for 5.5 hours after receiving her 1st  moderna vaccine
Tinnitis in left ear that started suddenly the day after vaccine. It began to resolve after about 7 months but not completely. The tinnitus was lessened .
(febrile) convuls w/no sequelae as of report 2MAY91;
HEADACHE; INJECTION SITE PAIN; EXTREME FATIGUE; This spontaneous report received from a patient concerned a 57 year old female. The patient's weight was 150 pounds, and height was 63 inches. The patient's concurrent conditions included psoriatic arthritis, occasional alcohol use, and non smoker, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting and had no known drug allergies. The patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 205A21A, and expiry: 23/JUN/2021) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. Concomitant medications included folic acid, methotrexate, and tofacitinib citrate. On 12-APR-2021, the subject experienced extreme fatigue. On 12-APR-2021, the subject experienced injection site pain. On 13-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from injection site pain, and had not recovered from extreme fatigue, and headache. This report was non-serious.
Information has been received from a consumer concerning her son who on 10/1/98, 12/1/98 and 12/7/99 was vaccinated with the 1st, 2nd and 3rd doses of Hep-B. Subsequently, the pt developed flu-like symptoms after each vaccination which lasted for approx. 1 week. Additionally, it was noted that liver function tests were abnormal after each vaccination. In April 2000, liver function testing was noted to be 100 which was considered high. The pt sought unspecified medical treatment. Additional information has been requested.
Information has been received from a physician concerning a 7 yr old white female student with no pre-existing allergies or medical conditions, who on 07Nov00 was vaccinated SC in the left arm with the first 0.5mL dose of varicella virus vaccine live (lot634515/0540K). There were no concomitant medications and there was no illness at the time of vaccination. The physician reported that on 10Jun05 (previously reported as 11Jun05), the pt developed a classic case of chickenpox characterized by a sore throat and fever for 2-3 days. It was also noted that the pt's chickenpox lesions were in various stages.  A doctor's visit was required, but no treatment was given. It was reported that the pt recovered as of 17Jun05. Additional information is not expected.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient's parent), for a Pfizer sponsored program (159558). A 15-year-old male patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), on May 17, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient had upper abdominal pain (stomach pain/achy in the stomach area), onset May 17, 2021, with outcome of unknown. Additional information: After the vaccination, patient had stomach pain. The patient was in the waiting area for 15 minutes with an  ache in his stomach area. He wanted to know if he could take Pepto Bismol and Tylenol for the stomach pain and whether it will interact with the vaccine. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Within one minute of receiving immunization child had repeated sneezing, large amount of mucus discharge nasally, difficulty breathing, wretching. Became lethargic, skin warm and dry. Pulse ox 88% on R/A wheezing bilat, itching of feet.
firmness under the injection site; Rash; redness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INDURATION (firmness under the injection site), INJECTION SITE RASH (Rash) and INJECTION SITE ERYTHEMA (redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced INJECTION SITE INDURATION (firmness under the injection site), INJECTION SITE RASH (Rash) and INJECTION SITE ERYTHEMA (redness). At the time of the report, INJECTION SITE INDURATION (firmness under the injection site), INJECTION SITE RASH (Rash) and INJECTION SITE ERYTHEMA (redness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Contact information(email) was updated. NNI
Pain level in left dislocated shoulder arm rose from a 3 to 7 level and now about a consistent 5.   Right upper arm had some pain and limit from rotator cuff but after the booster pain rose to 5/6 level and now difficult to raise arm even after some stretches which previously got arm movement to near normal.  Pain in either arm not relieved with meds (Tramadol 50mg) nor Motrin, Aleve, etc
expired vaccine used; this time pulled a Pfizer vial and gave that; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and EXTRA DOSE ADMINISTERED (this time pulled a Pfizer vial and gave that) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and EXTRA DOSE ADMINISTERED (this time pulled a Pfizer vial and gave that). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and EXTRA DOSE ADMINISTERED (this time pulled a Pfizer vial and gave that) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
terrible sleeping; arm from elbow to shoulder had a bruised feeling; dull headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (terrible sleeping), CONTUSION (arm from elbow to shoulder had a bruised feeling) and HEADACHE (dull headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced HYPERSOMNIA (terrible sleeping), CONTUSION (arm from elbow to shoulder had a bruised feeling) and HEADACHE (dull headache). At the time of the report, HYPERSOMNIA (terrible sleeping), CONTUSION (arm from elbow to shoulder had a bruised feeling) and HEADACHE (dull headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.
Parent states the day after vaccines patients leg was swollen, red and warm to the touch. Mom called the after hours nurse and was told to use cold compresses. Patient reports leg being itchy and a little sore. Doctor prescribed steroid cream for the itching.  Told mom to use Zyrtec/Benadryl. Mom was educated on signs of cellulitis and to call back if needed.
I got a red spot at the injection site. It hurts to touch but does not bother me otherwise. The red area is about an inch in diameter. There is swelling in about a two-inch diameter. The swollen place is hard to the touch.   I was advised by a pharmacist that this is not serious and to monitor the area.
Tonic Seizure, Complex Febrile Seizure lasting 45 minutes - 1 hour.
Gestational period at time of initial exposure: 4 (15 weeks, 5 days) months; 2nd Trimester; arm soreness; Headache; This is a spontaneous report from a contactable consumer in response to Non-HCP letter. This female consumer reported information for both mother and fetus. This is a maternal report.  A 38-year-old female patient received BNT162B2 (Pfizer/BioNTech Covid-19 vaccine, Age at the of vaccination: 38 years), dose 1 intramuscular, administered in arm left (left arm) on 28Apr2021 13:30 (Batch/Lot Number: EWC175, expiration date not reported) as dose 1, single for COVID-19 immunisation. Concomitant medication included prenatal vitamin via oral, gummy, daily, 2 per day starting from 12months (>2years (01Jan2018)) and ongoing as supplement. Medical history included mild covid infection week of 17Mar2020. Historical Vaccine included MMR vaccine booster received prior to pregnancy (positive Ab to measles, rubella, NOT mumps though- did not take). Family history included sporadic migraine for mother/ niece/ sister. The mother did not smoke during this pregnancy and did not drink alcohol during this pregnancy (a few drinks early- prior + pregnancy test (average<1 drink/day). No illicit drugs during this pregnancy. The father smoked (recreational (<1 per week)) and drank alcohol recreational (10 beers per week) during the mother pregnancy. No illicit drugs during the mother pregnancy. On 29Apr2021, the patient experienced headache next day and recovered with no treatment. On 29Apr2021 at, 1800, the patient experienced arm soreness and recovered with no treatment. The patient also received BNT162B2 (Pfizer/BioNTech Covid-19 vaccine), dose 2 intramuscular, administered in arm left (left arm) on 19May2021 0930 (Batch/Lot Number: EW0185, expiration date not reported) as dose 2, single for COVID-19 immunisation. The patient reported that she was in her first trimester of pregnancy and was considering enrolling in trial. However, it looked like no study sites within town, based on  website. The mother reported she became pregnant while taking BNT162B2. The mother was 16 weeks pregnant at the onset of the event. The mother was due to deliver on 15Oct2021. First day of last menstrual period was on 08Jan2021, estimated date of conception was 20Jan2021 and estimated delivery date was on 15Oct2021. Gestational period at time of initial exposure: 4 (15 weeks, 5 days) months; 2nd Trimester. The patient underwent lab tests and procedures which included Covid tests, many in 2020: Negative; on 19May2020: Positive (repeatedly positive over course of 5 months); on 27May2020: positive, on 01Sep2020: Negative, tested for antigen many times on an unspecified date and once available (summer 2020); all negative, no antigen test available at time of active infection; re-tested for antibody (Ab) several times to track possible loss of immunity over years (loss at 6months post- infection). The patient did not received treatment for the events. The outcome of the events arm soreness and headache was recovered on an unspecified date in 2021, whereas for another event it was unknown.  No follow-up attempts are needed. No further information is expected.
Swollen lymph node under left arm. Caused radiating pain through chest and down arm. Painful to move arm. Swelling and pain continues through today's date.
I started getting really itchy in my extremities I thought I had mosquito bites from the night before I was outside.  I also noticed the tips of my pointer and middle finger on my left hand felt numb.  The numbness has gone away but my hands and legs still  feel weak, people are saying that I have been walking funny. The itching wouldn?t stop and areas after I scratched 30 minutes or so later had what looked like dried puss. This has been happening for almost 2 weeks and it?s happening all over my extremities.  The itchiness is there as soon as I wake up, it goes away and comes back periodically. When I take my pants off it happens to my knees. I have scratched open flesh all over my body little scabs everywhere. I know it?s not poison ivy or anything like that because it comes and goes and I know it?s not hives.
I have reported adverse reaction to the first dose of vaccine, and was told to simply endure. I discussed those terrible adverse effects to two of the persons administering the second dose, and was assured with their theorizing that my second dose should have minimal side effects. Six hours after receiving the second dose I felt an unusual pressure buildup in the frontal area of head/brain. By the time I go home I was in full blown headache, and immediately laid down in bed for an hour. Felling a bit better I got up to watch TV, and went downhill rapidly from there. The headache would not respond to acetaminophen. I also could not eat anything, so drank cranberry juice and V8. Evening sleep was awakened with sweaty pillow and sheets. I had to sleep with towels on bed and pillow. Next day was headache and overall malaise all day. I washed two acetaminophen at 4:30pm with orange juice. An hour later as I vomited the orange juice. That evening was the same as the previous. But by the time I finally got up at 8:30am that second day, I was feeling much better. I will never, ever accept a corona-virus vaccine ever again.
Narrative: He reports having developed abdominal cramping a/w some constipation about 4 hors after the initial vaccination. This lasted for another 4-5 hours prior to resolving. He denied other common adverse effects including nausea and vomiting. He did not need to take any therapies and the cramping  resolved on its own.
Patient started feeling ill less than 24 hours after SHINGRIX administration. She is experiencing body aches, headache, fatigue, malaise, nausea, and decreased appetite. Patient will take TYLENOL or ibuprofen and wait another 1-2 days to see if symptoms improve.
Nonstop sinus drainage. 24/7 nose constantly running and post nasal drip into throat causing constant coughing and expectorating
Menstrual cycle unaffected for months of November and December. I ceased using birth control pills in early December and have not had a period since. My cycle is currently at 36 days and counting. I've never had a cycle last this long. I have taken many pregnancy tests in the last 2 weeks with negative results. I can't help but believe this is related to the COVID-19 vaccine.
The pt developed an itchy rash on palms and distal end of forearms, feet itchy. Erythema distal tibia area. Mild sore throat; no temperature; no cough; an episode of vomiting and diarrhea on 11/26/01. Seen on 11/28/01 with viral exanthem on feet and hands.
No Adverse reaction, however it was identified when patient arrived for 2nd dose that they were under 18. 2nd dose NOT given
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 25-JAN-2017 at 15:25, the patient was vaccinated with improperly stored VARIVAX injection (lot # M035142) (expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000433: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454.
Vaccine administered past published expiration date. Contacted Moderna, received this communication: The vaccine administered on November 10, 2021 and November 15, 2021 from lot number 046C21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration,? therefore there is no need for revaccination.